» Articles » PMID: 30903340

Distinguishing Early-stage Nasopharyngeal Carcinoma from Benign Hyperplasia Using Intravoxel Incoherent Motion Diffusion-weighted MRI

Overview
Journal Eur Radiol
Specialty Radiology
Date 2019 Mar 24
PMID 30903340
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: MRI can detect early-stage nasopharyngeal carcinoma (NPC), but the detection is more challenging in early-stage NPCs because they must be distinguished from benign hyperplasia in the nasopharynx. This study aimed to determine whether intravoxel incoherent motion diffusion-weighted imaging (IVIM DWI) MRI could distinguish between these two entities.

Methods: Thirty-four subjects with early-stage NPC and 30 subjects with benign hyperplasia prospectively underwent IVIM DWI. The mean pure diffusion coefficient (D), pseudo-diffusion coefficient (D*), perfusion fraction (f) and apparent diffusion coefficient (ADC) values were calculated for all subjects and compared between the 2 groups using Student's t test. Receiver operating characteristics with the area under the curve (AUC) was used to identify the optimal threshold for all significant parameters, and the corresponding diagnostic performance was calculated. A p value of < 0.05 was considered statistically significant.

Results: Compared with benign hyperplasia, early-stage NPC exhibited a significantly lower D mean (0.64 ± 0.06 vs 0.87 ± 0.11 × 10 mm/s), ADC mean (0.77 ± 0.08 vs 1.00 ± 0.13 × 10 mm/s), ADC (0.63 ± 0.05 vs 0.86 ± 0.10 × 10 mm/s) and a higher D* mean (32.66 ± 4.79 vs 21.96 ± 5.21 × 10 mm/s) (all p < 0.001). No significant difference in the f mean was observed between the two groups (p = 0.216). The D and ADC mean had the highest AUC of 0.985 and 0.988, respectively, and the D mean of < 0.75 × 10 mm/s yielded the highest sensitivity, specificity and accuracy (100%, 93.3% and 96.9%, respectively) in distinguishing early-stage NPC from benign hyperplasia.

Conclusion: DWI has potential to distinguish early-stage NPC from benign hyperplasia and D and ADC mean were the most promising parameters.

Key Points: • Diffusion-weighted imaging has potential to distinguish early-stage nasopharyngeal carcinoma from benign hyperplasia in the nasopharynx. • The pure diffusion coefficient, pseudo-diffusion coefficient from intravoxel incoherent motion model and apparent diffusion coefficient from conventional diffusion-weighted imaging were significant parameters for distinguishing these two entities in the nasopharynx. • The pure diffusion coefficient, followed by apparent diffusion coefficient, may be the most promising parameters to be used in screening studies to help detect early-stage nasopharyngeal carcinoma.

Citing Articles

Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinoma.

Ai Q, Leung H, Mo F, Mao K, Wong L, Liang Y Cancer Imaging. 2025; 25(1):32.

PMID: 40075537 PMC: 11905565. DOI: 10.1186/s40644-025-00854-4.


Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) combined with conventional MRI for the detection of skull-base invasion in nasopharyngeal carcinoma: comparison with F-sodium fluoride (F-NaF) positron emission tomography/computed....

Li Y, Liu Q, Wu W, Liu Z, Zhang Y, Dou Y Quant Imaging Med Surg. 2024; 14(9):6908-6921.

PMID: 39281160 PMC: 11400646. DOI: 10.21037/qims-24-745.


Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma.

Ai Q, King A, Tsang Y, Yu Z, Mao K, Mo F Eur Radiol. 2024; 35(3):1265-1275.

PMID: 39191996 PMC: 11836102. DOI: 10.1007/s00330-024-10948-5.


Magnetic resonance imaging based on radiomics for differentiating T1-category nasopharyngeal carcinoma from nasopharyngeal lymphoid hyperplasia: a multicenter study.

Cheng J, Su W, Wang Y, Zhan Y, Wang Y, Yan S Jpn J Radiol. 2024; 42(7):709-719.

PMID: 38409300 DOI: 10.1007/s11604-024-01544-0.


Differentiating nasopharyngeal carcinoma from lymphoma in the head and neck region using the apparent diffusion coefficient (ADC) value: a systematic review and meta-analysis.

Tabnak P, HajiEsmailPoor Z Pol J Radiol. 2023; 88:e472-e482.

PMID: 38020498 PMC: 10660142. DOI: 10.5114/pjr.2023.132172.


References
1.
King A, Wong L, Law B, Bhatia K, Woo J, Ai Q . MR Imaging Criteria for the Detection of Nasopharyngeal Carcinoma: Discrimination of Early-Stage Primary Tumors from Benign Hyperplasia. AJNR Am J Neuroradiol. 2017; 39(3):515-523. PMC: 7655321. DOI: 10.3174/ajnr.A5493. View

2.
Lai V, Li X, Lee V, Lam K, Fong D, Huang B . Nasopharyngeal carcinoma: comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging. Eur Radiol. 2013; 24(1):176-83. DOI: 10.1007/s00330-013-2995-7. View

3.
Chan K, Woo J, King A, Zee B, Lam W, Chan S . Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer. N Engl J Med. 2017; 377(6):513-522. DOI: 10.1056/NEJMoa1701717. View

4.
Xiao-Ping Y, Jing H, Fei-ping L, Yin H, Qiang L, Lanlan W . Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma. J Magn Reson Imaging. 2015; 43(5):1179-90. DOI: 10.1002/jmri.25075. View

5.
Thoeny H, De Keyzer F, King A . Diffusion-weighted MR imaging in the head and neck. Radiology. 2012; 263(1):19-32. DOI: 10.1148/radiol.11101821. View